QT Vascular Company
QT Vascular is a global company engaged in the development and commercialization of innovative devices for the minimally invasive treatment of vascular disease without the use of permanent implants (stents). QT Vascular is a Singapore-incorporated company focused on designing advanced therapeutic solutions for the treatment of complex vascular disease. Quattro Vascular was incorporated in 2010 to support the development of Chocolate® – the first interventional medical device developed in Singapore to receive FDA approval.
Headquarters:
Singapore, Central Region, Singapore
Funding Status:
Post-IPO Equity
Technology:
Other
Founded Date:
2010
Industry:
Personalized Medicine